(Q41329340)

29 September 2017

title

Hepatitis E virus and the safety of plasma products: investigations into the reduction capacity of manufacturing processes (English)

1 reference

29 September 2017

1 reference

Hepatitis E virus

1 reference

9

Thomas R Kreil

1 reference

29 September 2017

Maria R Farcet

1

1 reference

29 September 2017

Cornelia Lackner

2

1 reference

29 September 2017

Gerhard Antoine

3

1 reference

29 September 2017

Philip O Rabel

4

1 reference

29 September 2017

Andreas Wieser

5

1 reference

29 September 2017

Andreas Flicker

6

1 reference

29 September 2017

Ulrike Unger

7

1 reference

29 September 2017

Jens Modrof

8

1 reference

29 September 2017

publication date

24 September 2015

1 reference

29 September 2017

1 reference

29 September 2017

volume

56

1 reference

29 September 2017

issue

2

1 reference

29 September 2017

page(s)

383-391

1 reference

Hepatitis E: an emerging awareness of an old disease

29 September 2017

cites work

1 reference

Hepatitis E virus antibodies in blood donors, France

21 January 2018

1 reference

Hepatitis E virus infections in blood donors, France.

21 January 2018

1 reference

An assessment of hepatitis E virus (HEV) in US blood donors and recipients: no detectable HEV RNA in 1939 donors tested and no evidence for HEV transmission to 362 prospectively followed recipients

21 January 2018

1 reference

Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors?

21 January 2018

1 reference

A case of transfusion-transmitted hepatitis E caused by blood from a donor infected with hepatitis E virus via zoonotic food-borne route.

21 January 2018

1 reference

Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country.

21 January 2018

1 reference

Hepatitis E virus in blood components: a prevalence and transmission study in southeast England.

21 January 2018

1 reference

Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates

21 January 2018

1 reference

Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England.

21 January 2018

1 reference

Widespread distribution of hepatitis E virus in plasma fractionation pools

21 January 2018

1 reference

West Nile virus and the safety of plasma derivatives: verification of high safety margins, and the validity of predictions based on model virus data

21 January 2018

1 reference

Chikungunya virus and the safety of plasma products

21 January 2018

1 reference

H5N1 influenza virus and the safety of plasma products.

21 January 2018

1 reference

Development and evaluation of an efficient cell-culture system for Hepatitis E virus

21 January 2018

1 reference

Culture systems for hepatitis E virus

21 January 2018

1 reference

A549 and PLC/PRF/5 cells can support the efficient propagation of swine and wild boar hepatitis E virus (HEV) strains: demonstration of HEV infectivity of porcine liver sold as food

21 January 2018

1 reference

Thermal stability of hepatitis E virus assessed by a molecular biological approach

21 January 2018

1 reference

Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant

21 January 2018

1 reference

Adaptation of a genotype 3 hepatitis E virus to efficient growth in cell culture depends on an inserted human gene segment acquired by recombination

21 January 2018

1 reference

Reclassification of the Caliciviridae into distinct genera and exclusion of hepatitis E virus from the family on the basis of comparative phylogenetic analysis

21 January 2018

1 reference

A pathogenic picornavirus acquires an envelope by hijacking cellular membranes

21 January 2018

1 reference

Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation.

21 January 2018

1 reference

Extent of hepatitis E virus elimination is affected by stabilizers present in plasma products and pore size of nanofilters

21 January 2018

1 reference

Minor groove binder modification of widely used TaqMan probe for hepatitis E virus reduces risk of false negative real-time PCR results

21 January 2018

1 reference

One-hit models for virus inactivation studies

21 January 2018

1 reference

The evolution of down-scale virus filtration equipment for virus clearance studies

21 January 2018

1 reference

Implementation of a 20-nm pore-size filter in the plasma-derived factor VIII manufacturing process

21 January 2018

1 reference

A new liquid intravenous immunoglobulin with three dedicated virus reduction steps: virus and prion reduction capacity

21 January 2018

1 reference

Contribution to safety of immunoglobulin and albumin from virus partitioning and inactivation by cold ethanol fractionation: a data collection from Plasma Protein Therapeutics Association member companies

21 January 2018

1 reference

Thermal stability of hepatitis E virus

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/TRF.13343

1 reference

29 September 2017

1 reference